tiprankstipranks
Trending News
More News >
Cellcom Israel (CELJF)
OTHER OTC:CELJF
US Market

Cellcom (CELJF) Ratios

Compare
95 Followers

Cellcom Ratios

CELJF's free cash flow for Q4 2024 was 0.33. For the 2024 fiscal year, CELJF's free cash flow was decreased by and operating cash flow was 0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.75 0.83 1.05 1.05 1.19
Quick Ratio
0.68 0.77 0.98 1.00 1.15
Cash Ratio
0.18 0.24 0.40 0.38 0.37
Solvency Ratio
0.28 0.23 0.20 0.20 0.14
Operating Cash Flow Ratio
0.57 0.59 0.56 0.62 0.51
Short-Term Operating Cash Flow Coverage
1.71 1.97 1.83 2.75 1.93
Net Current Asset Value
-2.49B -2.72B -2.88B -2.85B -2.98B
Leverage Ratios
Debt-to-Assets Ratio
0.41 0.45 0.52 0.52 0.55
Debt-to-Equity Ratio
1.08 1.32 1.72 1.78 2.11
Debt-to-Capital Ratio
0.52 0.57 0.63 0.64 0.68
Long-Term Debt-to-Capital Ratio
0.35 0.43 0.52 0.55 0.60
Financial Leverage Ratio
2.65 2.93 3.33 3.42 3.81
Debt Service Coverage Ratio
1.51 1.56 1.51 2.00 1.39
Interest Coverage Ratio
2.85 2.27 2.17 1.29 -0.21
Debt to Market Cap
0.60 0.89 1.01 0.97 1.35
Interest Debt Per Share
16.84 18.96 23.01 21.99 26.82
Net Debt to EBITDA
1.75 2.07 2.41 2.52 3.67
Profitability Margins
Gross Profit Margin
31.73%30.45%29.44%27.73%23.83%
EBIT Margin
8.19%7.66%8.53%4.90%-1.12%
EBITDA Margin
29.43%27.63%27.42%26.83%24.02%
Operating Profit Margin
8.42%7.57%8.33%5.10%-0.87%
Pretax Profit Margin
5.24%4.32%4.70%0.95%-5.69%
Net Profit Margin
3.89%3.05%3.65%0.66%-4.62%
Continuous Operations Profit Margin
3.89%3.05%3.65%0.66%-4.62%
Net Income Per EBT
74.25%70.53%77.72%69.23%81.34%
EBT Per EBIT
62.30%57.06%56.42%18.66%653.13%
Return on Assets (ROA)
2.66%2.02%2.24%0.41%-2.38%
Return on Equity (ROE)
7.06%5.92%7.46%1.41%-9.04%
Return on Capital Employed (ROCE)
8.46%7.18%7.06%4.30%-0.61%
Return on Invested Capital (ROIC)
5.24%4.33%4.76%2.67%-0.44%
Return on Tangible Assets
3.94%2.99%3.24%0.61%-3.42%
Earnings Yield
5.07%5.10%5.45%0.95%-7.01%
Efficiency Ratios
Receivables Turnover
0.00 4.81 4.95 4.42 3.73
Payables Turnover
6.35 6.29 6.40 7.72 8.38
Inventory Turnover
20.23 26.83 25.93 33.67 38.36
Fixed Asset Turnover
2.06 2.04 2.01 2.04 1.81
Asset Turnover
0.68 0.66 0.61 0.62 0.51
Working Capital Turnover Ratio
-10.20 -34.09 48.31 17.83 5.64
Cash Conversion Cycle
-39.46 31.47 30.82 46.06 63.78
Days of Sales Outstanding
0.00 75.85 73.76 82.53 97.80
Days of Inventory Outstanding
18.05 13.60 14.08 10.84 9.52
Days of Payables Outstanding
57.50 57.99 57.02 47.30 43.54
Operating Cycle
18.05 89.46 87.84 93.37 107.32
Cash Flow Ratios
Operating Cash Flow Per Share
7.21 7.09 6.56 6.46 6.48
Free Cash Flow Per Share
3.20 3.08 2.95 2.79 3.23
CapEx Per Share
4.01 4.01 3.61 3.67 3.26
Free Cash Flow to Operating Cash Flow
0.44 0.43 0.45 0.43 0.50
Dividend Paid and CapEx Coverage Ratio
1.80 1.77 1.82 1.76 1.99
Capital Expenditure Coverage Ratio
1.80 1.77 1.82 1.76 1.99
Operating Cash Flow Coverage Ratio
0.45 0.39 0.30 0.31 0.25
Operating Cash Flow to Sales Ratio
0.27 0.27 0.25 0.26 0.27
Free Cash Flow Yield
15.53%19.41%16.81%15.96%20.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
19.73 19.60 18.34 105.38 -14.27
Price-to-Sales (P/S) Ratio
0.77 0.60 0.67 0.69 0.66
Price-to-Book (P/B) Ratio
1.39 1.16 1.37 1.48 1.29
Price-to-Free Cash Flow (P/FCF) Ratio
6.44 5.15 5.95 6.27 4.91
Price-to-Operating Cash Flow Ratio
2.86 2.24 2.68 2.70 2.44
Price-to-Earnings Growth (PEG) Ratio
0.69 -1.25 0.04 -0.91 -0.61
Price-to-Fair Value
1.39 1.16 1.37 1.48 1.29
Enterprise Value Multiple
4.36 4.23 4.85 5.11 6.42
EV to EBITDA
4.36 4.23 4.85 5.11 6.42
EV to Sales
1.28 1.17 1.33 1.37 1.54
EV to Free Cash Flow
10.76 10.09 11.81 12.38 11.47
EV to Operating Cash Flow
4.77 4.39 5.31 5.34 5.70
Tangible Book Value Per Share
2.08 0.71 -0.30 -1.28 -2.01
Shareholders’ Equity Per Share
14.80 13.68 12.83 11.80 12.28
Tax and Other Ratios
Effective Tax Rate
0.26 0.29 0.22 0.31 0.19
Revenue Per Share
26.82 26.58 26.21 25.19 24.00
Net Income Per Share
1.04 0.81 0.96 0.17 -1.11
Tax Burden
0.74 0.71 0.78 0.69 0.81
Interest Burden
0.64 0.56 0.55 0.19 5.10
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.01 <0.01 <0.01 <0.01 0.01
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
6.91 8.75 6.85 38.96 -5.84
Currency in ILS
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis